Extract from the Register of European Patents

EP About this file: EP0820323

EP0820323 - METERED DOSE INHALER FOR SALMETEROL [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  29.08.2008
Database last updated on 21.03.2026
Most recent event   Tooltip29.08.2008Revocation of patentpublished on 01.10.2008  [2008/40]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza, P.O. Box 7929 Philadelphia
Pennsylvania 19101-7929 / US
[N/P]
Former [2002/47]For all designated states
SmithKline Beecham Corporation
One Franklin Plaza, P.O. Box 7929
Philadelphia, Pennsylvania 19101-7929 / US
Former [1998/05]For all designated states
GLAXO WELLCOME INC.
5 Moore Drive, Box 13398
Research Triangle Park, North Carolina 27709 / US
Inventor(s)01 / ASHURST, Ian, C.
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
02 / HERMAN, Craig, S.
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
03 / LI, Li
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
04 / RIEBE, Michael, T.
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
05 / BRITTO, Ignatius Loy
Glaxo Wellcome Inc., 5 Moore Drive
PO Box 13398, NC 27709-3398 / US
[2000/03]
Former [1998/05]01 / ASHURST, Ian, C.
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
02 / HERMAN, Craig, S.
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
03 / LI, Li
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
04 / RIEBE, Michael, T.
Glaxo Wellcome Inc. 5 Moore Drive
Research Triangle Park, NC 27709 / US
Representative(s)Cooke, Tracey
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2005/40]Cooke, Tracey
GlaxoSmithKline, Corporate Intellectual Property (CN9.25.1), 980 Great West Road Brentford
Middlesex TW8 9GS / GB
Former [2005/32]Cooke, Tracey
GlaxoSmithKline Corporate Intellectual Property Two New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Former [1998/05]Quillin, Helen Kaye, et al
Glaxo Wellcome plc Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Application number, filing date96911712.610.04.1996
[1998/05]
WO1996US05005
Priority number, dateUS1995042237014.04.1995         Original published format: US 422370
US1996058333205.01.1996         Original published format: US 583332
[1998/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9632150
Date:17.10.1996
Language:EN
[1996/46]
Type: A1 Application with search report 
No.:EP0820323
Date:28.01.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.1996 takes the place of the publication of the European patent application.
[1998/05]
Type: B1 Patent specification 
No.:EP0820323
Date:24.09.2003
Language:EN
[2003/39]
Search report(s)International search report - published on:EP17.10.1996
ClassificationIPC:A61M15/00, B65D83/14
[2003/15]
CPC:
B65D83/52 (EP,US); A61M15/00 (KR); A61M15/009 (EP,US);
A61M2205/0222 (EP,US); A61M2205/0233 (EP,US)
Former IPC [1998/05]A61M15/00, B65D83/14, B05D5/08
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/05]
Extension statesAL03.10.1997
LT03.10.1997
LV03.10.1997
SI03.10.1997
TitleGerman:DOSIERINHALATOR FÜR SALMETEROL[1998/05]
English:METERED DOSE INHALER FOR SALMETEROL[1998/05]
French:INHALATEUR DOSEUR DE SALMETEROL[1998/05]
Entry into regional phase03.10.1997National basic fee paid 
03.10.1997Designation fee(s) paid 
03.10.1997Examination fee paid 
Examination procedure07.11.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
03.10.1997Examination requested  [1998/05]
21.06.1999Amendment by applicant (claims and/or description)
08.04.2002Despatch of a communication from the examining division (Time limit: M05)
16.09.2002Reply to a communication from the examining division
20.03.2003Communication of intention to grant the patent
04.07.2003Fee for grant paid
04.07.2003Fee for publishing/printing paid
Divisional application(s)EP03017935.2  / EP1366777
EP05075583.4  / EP1547636
EP07025253.1  / EP1908488
Opposition(s)Opponent(s)01  24.06.2004    ADMISSIBLE
3M Innovative Properties Company
3M Center
P.O. Box 33427
St. Paul MN 55133-3427 / US
Opponent's representative
Aleandri-Hachgenei, Lorraine E.
3M Deutschland GmbH
Office of Intellectual Property Counsel
Carl-Schurz-Strasse 1
41453 Neuss / DE
 [N/P]
Former [2004/34]
Opponent(s)01  24.06.2004    ADMISSIBLE
3M Innovative Properties Company 3M General Offices St. Paul
P.O. Box 33427
St. Paul, Minnesota 55133-3427 / US
Opponent's representative
Aleandri-Hachgenei, Lorraine E.
3M Deutschland GmbH, Office of Intellectual Property Counsel, Carl-Schurz-Strasse 1
41453 Neuss / DE
03.08.2004Invitation to proprietor to file observations on the notice of opposition
14.02.2005Reply of patent proprietor to notice(s) of opposition
30.11.2005Date of oral proceedings
21.12.2005Despatch of interlocutory decision in opposition
21.12.2005Despatch of minutes of oral proceedings
28.02.2008Legal effect of revocation of patent [2008/40]
28.02.2008Despatch of communication that the patent will be revoked
Appeal following opposition17.02.2006Appeal received No.  T0226/06
20.04.2006Statement of grounds filed
28.02.2008Result of appeal procedure: revocation of the patent
28.02.2008Date of oral proceedings
Fees paidRenewal fee
14.04.1998Renewal fee patent year 03
14.04.1999Renewal fee patent year 04
13.04.2000Renewal fee patent year 05
12.04.2001Renewal fee patent year 06
12.04.2002Renewal fee patent year 07
07.04.2003Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.